 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 171 - 180 of 1028:
Evidence On The Safety And Effectiveness Of Ephedra:
More than half of the population of the United States uses "dietary supplements," as the term is defined in the Dietary Supplement Health and Educatio...
Evidence On The Safety And Effectiveness Of Ephedra: Implications For Regulation
More than half of the population of the United States uses "dietary supplements," as the term is defined in the Dietary Supplement Health and Educatio...
Exact Sciences 'Surprised' By FDA Warning Letter
The Food and Drug Administration’s [FDA] Office of In Vitro Diagnostic Device Evaluation and Safety issued a Warning Letter to cancer test developer E...
Exciting Developments At The FDA - Annual Meeting Of The American Urological Association
Dr. Andrew von Eschenbach discussed developments at the FDA. He addressed the FDA mission to protect and promote public health. The FDA has been in ex...
F.D.A. and Disk Maker Questioned
A ranking member of the Senate Finance Committee has asked the Food and Drug Administration and the maker of an artificial spinal disk about potential...
F.D.A. Criticizes Avastin Use for Breast Cancer
Genentech’s drug Avastin did not help women with breast cancer live meaningfully longer, and it caused significant side effects, including a few death...
F.D.A. Finds Increase in Suicide Symptoms for Patients Using Seizure Medications
Drugs for epilepsy, bipolar illness and mood problems double the risks of suicidal thoughts and behavior, and patients taking them should be watched f...
F.D.A. Is Reviewing Heartburn Drugs After Studies Find Possible Heart Risk
Two small studies of the popular heartburn drugs Prilosec and Nexium found that patients who took the medicines over many years had an increased risk ...
F.D.A. on the Brink?
You know something is seriously amiss when industry scientists, consumer groups, and a bipartisan phalanx of senior government officials past and pres...
F.D.A. Panel Votes to Keep Diabetes Drug on Market
A federal drug advisory committee voted 20 to 3 late this afternoon that Avandia, a controversial diabetes drug made by GlaxoSmithKline, raises the ri... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |